These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28255643)

  • 1. Use of etanercept to treat rheumatoid arthritis in an HIV-positive patient: a case-based review.
    Liang SJ; Zheng QY; Yang YL; Yang Y; Liu CY
    Rheumatol Int; 2017 Jul; 37(7):1207-1212. PubMed ID: 28255643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease.
    Cepeda EJ; Williams FM; Ishimori ML; Weisman MH; Reveille JD
    Ann Rheum Dis; 2008 May; 67(5):710-2. PubMed ID: 18079191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of antitumor necrosis factor-alpha biological therapy in managing human immunodeficiency virus-associated arthritis: three case studies from Saudi Arabia.
    Almoallim H; Jali I; Wali G
    Joint Bone Spine; 2013 Jul; 80(4):426-8. PubMed ID: 23453475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unaffected reaction level in tuberculin skin test by long-term therapy with tumor necrosis factor inhibitors for rheumatoid arthritis.
    Yamamoto S; Nagatani K; Sato T; Iwamoto M; Takatori S; Minota S
    Int J Rheum Dis; 2017 May; 20(5):584-588. PubMed ID: 28524434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EFFECT OF THERAPY WITH ANTI-TNF α DRUGS AND DMARD ON DISEASE ACTIVITY AND HEALTH RELATED QUALITY OF LIFE AMONG WOMEN WITH RHEUMATOID ARTHRITIS.
    Kopciuch D; Paczkowska A; Leszczynsk P; Michalak M; Nowakowskai E
    Acta Pol Pharm; 2016; 73(2):547-54. PubMed ID: 27180448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study.
    Lin KM; Cheng TT; Lin JC; Chen CJ
    Clin Rheumatol; 2015 Jun; 34(6):1039-46. PubMed ID: 25939523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etanercept for the treatment of rheumatoid arthritis.
    Zhao S; Mysler E; Moots RJ
    Immunotherapy; 2018 Mar; 10(6):433-445. PubMed ID: 29482402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
    JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis.
    Koike R; Takeuchi T; Eguchi K; Miyasaka N;
    Mod Rheumatol; 2007; 17(6):451-8. PubMed ID: 18084695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation.
    Lin YC; Lin YC; Wu CC; Huang MY; Tsai WC; Hung CH; Kuo PL
    Oncotarget; 2017 Jan; 8(5):7559-7571. PubMed ID: 27926504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of omics in predicting anti-TNF efficacy in rheumatoid arthritis.
    Xie X; Li F; Li S; Tian J; Chen JW; Du JF; Mao N; Chen J
    Clin Rheumatol; 2018 Jan; 37(1):13-23. PubMed ID: 28600618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of anti-tumor necrosis factor biologics in the treatment of rheumatoid arthritis does not change human T-lymphotropic virus type 1 markers: a case series.
    Umekita K; Umeki K; Miyauchi S; Ueno S; Kubo K; Kusumoto N; Takajo I; Nagatomo Y; Okayama A
    Mod Rheumatol; 2015 Sep; 25(5):794-7. PubMed ID: 24252020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: analysis from BIOBADABRASIL.
    Fafá BP; Louzada-Junior P; Titton DC; Zandonade E; Ranza R; Laurindo I; Peçanha P; Ranzolin A; Hayata AL; Duarte A; Silveira IG; Costa I; Macieira JC; Guedes-Barbosa LS; Bertolo MB; Sauma MF; Silva MB; Freire M; Scheinberg MA; Fernandes V; Bianchi W; Miranda JR; Pinheiro GR; Carvalho HM; Brenol CV; Pereira IA; de Castro GR; de Morais JC; Oliveira SK; de Abreu MM; Toledo RA; Pinheiro MM; Vieira WP; Valim V;
    Clin Rheumatol; 2015 May; 34(5):921-7. PubMed ID: 25851594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-Year Tuberculosis Risk in Rheumatoid Arthritis Patients Starting Their First Tumor Necrosis Factor Inhibitor Therapy from 2008 to 2012 in Taiwan: A Nationwide Population-Based Cohort Study.
    Lim CH; Lin CH; Chen DY; Chen YM; Chao WC; Liao TL; Chen HH
    PLoS One; 2016; 11(11):e0166339. PubMed ID: 27832150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of a tumor necrosis factor inhibitor-adalimumab-in the management of arthritis in an adolescent with HIV: A case report.
    Bakry R; Bokhary N; Sendi E; Alshehri M; Sindi L; Alkwai H
    Int J Rheum Dis; 2024 Jan; 27(1):e14827. PubMed ID: 37431718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
    Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
    Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of 24 months of anti-TNF therapy versus methotrexate on body weight in patients with rheumatoid arthritis: a prospective observational study.
    Sfriso P; Caso F; Filardo GS; Botsios C; Costa L; Scarpa R; Todesco S; Spinella P; Oliviero F; Punzi L
    Clin Rheumatol; 2016 Jun; 35(6):1615-8. PubMed ID: 27048267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence with anti-tumor necrosis factor therapies in patients with rheumatoid arthritis: observations from the RADIUS registry.
    Markenson JA; Gibofsky A; Palmer WR; Keystone EC; Schiff MH; Feng J; Baumgartner SW
    J Rheumatol; 2011 Jul; 38(7):1273-81. PubMed ID: 21572150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF inhibitors - new and old agents for rheumatoid arthritis.
    Simsek I
    Bull NYU Hosp Jt Dis; 2010; 68(3):204-10. PubMed ID: 20969553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.